Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
failed trials
Biotech
2025's top 10 clinical trial flops
Fierce Biotech looks back at 10 of the most impactful and interesting clinical failures of 2025.
James Waldron
,
Nick Paul Taylor
Feb 9, 2026 3:00am
Amgen eyes lupus redemption while cancer candidate struggles
Feb 4, 2026 6:10am
Sanofi GCS inhibitor fails ph. 3 Fabry trial but wins in Gaucher
Feb 2, 2026 5:46am
Pulmocide pulls ph. 3 antifungal trial over mortality rate
Jan 7, 2026 10:57am
Neuro biotech Nido closes after 5 years
Jan 2, 2026 10:24am
Ultragenyx plans cost-cutting push after flunking phase 3 trials
Jan 2, 2026 5:37am